Why the study?
Does extracorporeal ultrafiltration improve management of hypervolemia in patients with congestive refractory heart failure?
Does extracorporeal ultrafiltration improve management of hypervolemia in patients with congestive refractory heart failure?
This review highlights extracorporeal ultrafiltration as a safe and effective therapeutic option for managing hypervolemia in refractory heart failure.
Answers are grounded in this paper and cite their sources.
May support ultrafiltration for refractory HF hypervolemia; leaves open need for randomized confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Mircheva et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: